Insulet Reports Second Quarter 2020 Revenue Increase of 28% Year-Over-Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Insulet (PODD) Tops Q2 EPS by 22c, Revs Beat
August 6, 2020 4:55 PM EDTInsulet (NASDAQ: PODD) reported Q2 EPS of $0.22, $0.22 better than the analyst estimate of $0.00. Revenue for the quarter came in at $226.3 million versus the consensus estimate of $212.41 million.
"Thanks to our teams relentless focus on our mission and the strength and durability of our recurring revenue model, we delivered another quarter of financial and operational results that... More
